NanoViricides is trading 13.67% higher at $1.58 in pre-market on October 23, compared with the October 22 close of $1.39. No new company-specific announcement clearly explaining the move was found.
- Recent coverage included October 20 juvenile-mouse safety results for NV-387 and a reported $2.375 million stock-offering prospectus; neither is confirmed as the cause of the gain.
- Available market context is broadly negative and does not clearly explain the upward move.